JW (Cayman) Therapeutics Co. Ltd
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, inclu…
Biotechnology
CN, Shanghai [HQ]
Balance Sheet
6 Sheets · From 2023 to 2018Configuration
In Million CNY. Margins, Growth Rates In %
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Assets | 340.00 | 668.00 | 3,779.00 | 3,116.00 | 2,791.00 | 2,146.00 | |
|
Current
|
171.00 | 261.00 | 2,647.00 | 1,895.00 | 1,485.00 | 1,067.00 | |
| Cash And Equivalents | 133.00 | 254.00 | 2,630.00 | 1,834.00 | 1,383.00 | 1,005.00 | |
| Assets | 340.00 | 668.00 | 3,779.00 | 3,116.00 | 2,791.00 | 2,146.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | -5.00 | 5.00 | |
| Inventory | - - | - - | - - | 31.00 | 40.00 | 34.00 | |
| Short Term Investments | - - | - - | - - | - - | 5.00 | 5.00 | |
| Other Current Assets | 37.00 | 6.00 | 14.00 | 28.00 | 50.00 | 4.00 | |
|
Non Current
|
169.00 | 359.00 | 1,082.00 | 1,181.00 | 1,286.00 | 1,078.00 | |
| Property, Plant, Equipment (Net) | 77.00 | 202.00 | 307.00 | 365.00 | 393.00 | 343.00 | |
|
Intangible Assets
|
80.00 | 156.00 | 774.00 | 816.00 | 893.00 | 718.00 | |
| Goodwill | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | - - | - - | - - | |
| Other Non Current Assets | 12.00 | -359.00 | -1,082.00 | -1,181.00 | -1,286.00 | 17.00 | |
| Liabilities | 654.00 | 1,610.00 | 349.00 | 325.00 | 437.00 | 462.00 | |
|
Current
|
225.00 | 122.00 | 237.00 | 198.00 | 310.00 | 264.00 | |
| Accounts Payable | - - | - - | - - | - - | 11.00 | - - | |
| Short Term Debt | 43.00 | 10.00 | 10.00 | 20.00 | 152.00 | 121.00 | |
| Deferred Revenue | -8.00 | -10.00 | -10.00 | -20.00 | -152.00 | 105.00 | |
| Tax Payable | - - | - - | 1.00 | 5.00 | 4.00 | 6.00 | |
| Other Current Liabilities | 182.00 | 115.00 | 212.00 | 126.00 | 239.00 | 34.00 | |
|
Non Current
|
428.00 | 1,471.00 | 100.00 | 95.00 | 92.00 | 197.00 | |
| Long Term Debt | 15.00 | 1,471.00 | 100.00 | 95.00 | 92.00 | 197.00 | |
| Leasing Obligations | 18.00 | 26.00 | 23.00 | 47.00 | 44.00 | 56.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | - - | |
| Other Non Current Liabilities | 413.00 | -1,471.00 | -100.00 | -95.00 | -92.00 | - - | |
| Equity | -313.00 | -942.00 | 3,429.00 | 2,790.00 | 2,354.00 | 1,683.00 | |
| Stockholders' Equity | -313.00 | -942.00 | 3,429.00 | 2,790.00 | 2,354.00 | 1,683.00 | |
| Retained Earnings | -351.00 | -985.00 | -2,648.00 | -3,351.00 | -4,197.00 | -4,965.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | 2.00 | - - | - - | - - | - - | - - | |
| Profit | -272.00 | -633.00 | -1,663.00 | -702.00 | -846.00 | -767.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 40.00 | 40.00 | 6,023.00 | 6,080.00 | 6,080.00 | - - | |
| Loss Other Compr. Income | -2.00 | 2.00 | 55.00 | 61.00 | 470.00 | 6,649.00 |